OPPENHEIMER & CO INC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 2 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$4,000
-71.4%
12,175
-36.3%
0.00%
Q3 2021$14,000
-69.6%
19,125
-50.0%
0.00%
-100.0%
Q2 2021$46,000
-13.2%
38,250
-2.5%
0.00%0.0%
Q1 2021$53,000
-31.2%
39,250
-38.9%
0.00%
-50.0%
Q4 2020$77,000
-20.6%
64,250
+4.7%
0.00%0.0%
Q3 2020$97,000
+59.0%
61,350
+25.3%
0.00%0.0%
Q2 2020$61,000
+32.6%
48,950
+14.2%
0.00%
+100.0%
Q1 2020$46,000
-61.0%
42,850
-11.8%
0.00%
-66.7%
Q4 2019$118,000
-41.0%
48,600
-11.5%
0.00%
-40.0%
Q3 2019$200,000
-22.2%
54,900
-44.3%
0.01%
-28.6%
Q2 2019$257,000
+22.4%
98,561
+129.0%
0.01%
+16.7%
Q1 2019$210,000
-13.2%
43,035
-32.1%
0.01%
-25.0%
Q4 2018$242,000
-43.2%
63,381
-2.1%
0.01%
-27.3%
Q3 2018$426,000
+16.4%
64,768
+10.1%
0.01%
+10.0%
Q2 2018$366,000
+8.6%
58,834
-14.9%
0.01%
+11.1%
Q1 2018$337,000
-27.2%
69,129
-9.9%
0.01%
-25.0%
Q4 2017$463,000
+17.8%
76,758
+3.3%
0.01%
+9.1%
Q3 2017$393,000
+4.0%
74,279
+3.6%
0.01%
+10.0%
Q2 2017$378,000
+26.8%
71,706
+72.9%
0.01%
+25.0%
Q1 2017$298,000
+142.3%
41,466
+94.5%
0.01%
+100.0%
Q4 2016$123,00021,3180.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 1,575,000$10,080,0000.84%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,152,0000.80%
GILDER GAGNON HOWE & CO LLC 5,045,685$32,292,0000.63%
EAM Investors, LLC 508,483$3,254,0000.51%
STONERIDGE INVESTMENT PARTNERS LLC 468,986$3,002,0000.44%
1492 Capital Management LLC 41,132$263,0000.22%
HEARTLAND ADVISORS INC 600,000$3,840,0000.20%
OUTFITTER ADVISORS, LTD. 63,532$407,0000.16%
Piermont Capital Management Inc. 66,240$424,0000.14%
GAM Holding AG 1,202,729$7,697,0000.13%
View complete list of THERAPEUTICSMD INC shareholders